Latest Breaking News On - Co alzheimer - Page 2 : comparemela.com

(Reuters) - The U.S. health regulator's rejection of accelerated approval for Eli Lilly and Co's Alzheimer's disease drug extends the market lead for .

Shailesh kuberAndrew baumKhushi mandowaraMichael yeeEli lillyBrian skorneyEisai co ltdCo alzheimerDrug administrationBiogen inc